CRWD closed at $268.02 on October 27, up 2.36% (+$6.19) from $261.83, on 7.29M shares - the third consecutive advance and a cumulative +12.64% from the $237.94 October 22 close - with an intraday high of $271.03 that pushed into the $268.95 September 30 high and the $270.04 October 2 close for the first time since the October 7-22 drawdown. The tape helped: fell another 4.73% to 17.52, the Nasdaq rose 1.18%, the S&P 500 0.60% and the Russell 2000 1.16%, while the 10-year held at 4.99%. Internal repair is nearly complete - the histogram has improved five straight sessions to -0.0818 from the -6.7200 trough on October 20 (98.8% of the gap closed) with the line at 2.7202 against a 2.8019 signal, (14) advanced to 60.35 and rose 7.29M to 190.80M. Participation is the problem: volume fell to 7.29M, only 0.85x the 20-day average of 8.60M and 0.77x the 60-day average of 9.44M, and well below the 13.40M breakout session and 8.47M follow-through - a third straight up day on shrinking volume straight into the heaviest supply shelf on the chart. Long-term structure was never threatened (price 12.42% above the at $238.41 and 50.67% above the at $177.88, with the 34.03% above the ), but the stock now sits 8.40% ABOVE the $247.25 consensus mean target and 7.21% above the $250 median. Fundamentals remain strong and unchanged: 25.8% revenue growth, a 75.19% gross margin, $1.995B of free cash flow against $820.18M of debt ($4.19B net cash, just 1.53% of the $274.44B market cap), six beats in six supplied quarters averaging 5.94%, and FY estimates showing 48 upward versus 1 downward revision over the past 30 days. Valuation is the binding constraint and the rally made it worse: forward 166.34x on next-year of $1.61123, price-to-sales 50.86x, 6.76, price-to-book 53.79x and a 0.73% free-cash-flow yield. No article in the bundle is newer than September 30, so the three-session 12.6% advance still has no identifiable public catalyst and is flow-driven until proven otherwise. The stance stays HOLD with a lower score of 52: HOLD for one month because the easy 12.6% has already been captured and new money would be entering 8.4% above consensus into resistance on declining volume, HOLD for six months into the December 1 print now confirmed 34 days out, and SELL for one year because at 166.34x forward earnings a full year of roughly 28% growth is already discounted and a rerating to 140x implies $225.57 (-15.8%), 125x $201.40 (-24.9%) and 110x $177.24 (-33.9%). Key levels are $256.08 and $246.36 below and $271.03, $274.23 and $286.99 above.
投资判断
实时价格
$264.84
推荐分数
52%
52%
置信度
65%
65%
各期限展望
1个月
持有
短线
6个月
持有
中期
1年
卖出
长期
核心催化
There is no new fundamental news in the bundle - the newest article is still dated September 30 - so the single most important item is the absence of a catalyst for a 12.64% three-session advance that has now pushed CRWD 8.40% above the consensus mean target on declining volume. The Falcon listing in the OpenAI Marketplace remains the only plausible fundamental driver that could organically justify a 166.34x forward multiple, but no bookings, revenue, joint-customer counts, sales-cycle changes or AI-focused deal sizes have been disclosed. The next scheduled opportunity to quantify it is now confirmed as the December 1, 2026 report, 34 days out - which makes that print the dominant binary for anyone holding this stock beyond the next month.
Keep exposure at half-normal size or less inside a Satellite Upside sleeve, and do not chase the $268.02 close. The breakout is legitimate and now three sessions old - a fresh $271.03 high, a third close above the $256.08 and a fifth straight session of histogram improvement - but the entry is 8.40% above the consensus mean target on the lightest volume of the three up sessions (7.29M, 0.85x the 20-day average) with an of $12.57 (4.69% of price) and 20-day realized volatility at 56.3%, so risk per unit of reward is materially worse here than on a retest toward $250-$258. The next report is confirmed 34 days out; any position carried into it must be sized for a 10%+ gap, which on a ~4.7% stock is routine.
投资逻辑快照
什么情况涨
The October 23 breakout has now been confirmed twice rather than faded, and that is the strongest argument for owning CRWD here. The stock added 2.36% on October 27 to $268.02 after +1.65% on October 26 and +8.25% on October 23, printing a session high of $271.03 that traded into the $268.95 September 30 high for the first time since the October 7-22 drawdown - a cumulative +12.64% from the $237.94 October 22 close, with the October 27 low of $260.34 never threatening the breakout. It happened in a genuinely supportive tape ( -4.73% to 17.52, Nasdaq +1.18%, Russell 2000 +1.16%, S&P 500 +0.60%) and momentum is one session from a clean flip: the line at 2.7202 is within 0.08 of its 2.8019 signal after the histogram narrowed five consecutive sessions from -6.7200 on October 20 to -0.0818 (98.8% of the gap closed), (14) is 60.35 and rising without being overbought, and has added 29.15M since the October 22 trough to 190.80M. The long-term structure was never broken - price is 50.67% above the at $177.88 with the 34.03% above it. And the franchise keeps beating: 25.8% revenue growth, a 75.19% gross margin, $1.995B of free cash flow, $4.19B of net cash, six beats in six supplied quarters averaging 5.94%, 48 upward versus 1 downward FY revision over 30 days, and a target ladder from Mizuho at $275 to Freedom Broker at $320. Prior targets validated the framework rather than embarrassing it: the $250-$258 entry zone was touched on October 26 at a $254.06 low and the $272 lower exit edge was missed by only $1.05 on October 27. If the flow persists, $274.23 is the next stop and the Street has to chase it toward $286.99.
什么情况跌
The strongest argument against owning CRWD is that the entire 12.64% three-session advance has no identifiable catalyst in the supplied news - the newest article is dated September 30 - and each successive leg came on lighter volume: 13.40M on October 23, 8.47M on October 26, 7.29M on October 27, the last only 0.85x the 20-day average and 0.77x the 60-day. A breakout that decelerates in participation as it approaches resistance is the classic signature of short-covering or momentum flow rather than institutional accumulation, and flow that arrives unexplained in a stock with 56.3% realized volatility can leave the same way. Everything that made the stock expensive on October 22 is still true, only more so: the forward is now 166.34x on next-year of $1.61123, trailing 5,360.4x, price-to-sales 50.86x against a cited Software-industry average near 3.7x, 6.76 and a free-cash-flow yield of 0.73%. A full year of expected ~28.2% growth is already in the price, so a derating to 140x implies $225.57 (-15.8%), 125x about $201.40 (-24.9%) and 110x about $177.24 (-33.9%), all with estimates unchanged. The consensus has been left further behind rather than vindicated - the $247.25 mean and $250 median now sit 8.40% and 7.21% BELOW spot, versus 5.57% and 4.73% on October 26 - so the sell side must raise targets to validate a price it did not forecast. Fundamental momentum is not accelerating: FY26 is still 1.8% below its 60-day level and 2.0% below its 90-day level, FY27 1.2% below its 60-day level, GAAP operating margin is -2.26%, and the OpenAI Marketplace contribution is entirely undisclosed. Technically the confirmation is still incomplete: the histogram is negative at -0.0818 with the line below its signal, and at 190.80M remains 13.5% below the October 6 peak of 220.59M, so the September-October distribution has not been absorbed. And the December 1 report, now confirmed 34 days out, is a binary on a stock where one is $12.57.
A daily close below $256.08 (the ) would be the first warning that the three-day advance is failing; a daily close below $246.36 - the October 22 high broken on October 23 - would mark the whole move as a squeeze rather than a change of character and put the $238.41 back in play, and a close below that would confirm resumption of the October 7-22 downtrend and reopen $228.70 and $221.36. On the upside, the thesis is validated by a close above the $271.03-$274.23 October supply band on volume at or above 13.4M shares with pushing back toward the October 6 peak of 220.59M, which would open the $286.99 52-week high and force the $275-$325 target cluster into play; failure to clear that band on the current declining volume, followed by a close back under $260, would confirm a failed retest.
Multiple compression: forward 166.34x on next-year of $1.61123, trailing 5,360.4x, price-to-sales 50.86x, 6.76, price-to-book 53.79x, roughly 2,470x and a 0.73% free-cash-flow yield; a rerating to 140x implies roughly $225.57 (about 15.8% below the $268.02 close), 125x about $201.40 (about 24.9% below) and 110x about $177.24 (about 33.9% below), in every case with estimates unchanged.
Deteriorating participation and reversal risk: the three-session 12.64% advance has no dated catalyst in the bundle and decelerating volume (13.40M, then 8.47M, then 7.29M, or 0.85x the 20-day and 0.77x the 60-day average), while at 190.80M is still 13.5% below the October 6 peak of 220.59M, short interest is 2.60% of float with a 2.26-day short ratio and no historical short series is supplied - so squeeze mechanics cannot be distinguished from genuine accumulation.
Estimate and execution risk: revenue is growing 25.8% but current-year of $1.25679 is 1.8% below its 60-day level and 2.0% below its 90-day level, FY27 of $1.61123 is 1.2% below its 60-day level, GAAP operating margin is -2.26%, the OpenAI Marketplace bookings, revenue and customer counts remain undisclosed, and the December 1, 2026 report just 34 days away must defend a 166.34x forward multiple that consensus targets no longer bracket.
Macro and rate risk: the 10-year Treasury at 4.99% sits near the top of its recent range and is the direct lever on a 166.34x multiple, while with beta of 1.197, 20-day realized volatility of 56.3% and at 4.69% of price ($12.573) a single adverse session can move the shares $13 or more - enough to erase the entire $256.08-to-$246.36 support shelf in one close.
接下来关注
下一次财报：2026年12月1日
There is no new fundamental news in the bundle - the newest article is still dated September 30 - so the single most important item is the absence of a catalyst for a 12.64% three-session advance that has now pushed CRWD 8.40% above the consensus mean target on declining volume. The Falcon listing in the OpenAI Marketplace remains the only plausible fundamental driver that could organically justify a 166.34x forward multiple, but no bookings, revenue, joint-customer counts, sales-cycle changes or AI-focused deal sizes have been disclosed. The next scheduled opportunity to quantify it is now confirmed as the December 1, 2026 report, 34 days out - which makes that print the dominant binary for anyone holding this stock beyond the next month.
信号仪表盘
决策输入
6 个信号
基本面
-7.8%
距分析师均值目标空间
At $268.02 the trailing of 5,360.4x is not decision-useful given a 0.834% net profit margin, and the decision-useful number is the forward of 166.34x measured on next-year consensus of $1.61123 - up from 162.50x on October 26 and 159.86x on October 23 purely because the price gained another 2.36%, on an otherwise unchanged fundamental base. That means a full year of expected ~28.2% growth ($1.25679 to $1.61123) is already embedded: if the multiple merely holds at 166.34x the stock returns only that growth, and any positive excess return requires further multiple expansion from an already extreme level. A rerating to 140x next-year implies roughly $225.57 (-15.8% from spot), 125x about $201.40 (-24.9%) and 110x about $177.24 (-33.9%), in every case with estimates unchanged. Price-to-sales of 50.86x compares with the roughly 3.7x Software-industry average and 14.9x peer-group average cited in the September 30 Simply Wall St article, though those benchmarks are indicative rather than a fully matched peer study; is 6.76, more than 4x the customary 1.5x growth-stock reference; price-to-book is 53.79x. of about 2,470x is economically uninformative at a 1.98% margin. Enterprise value of $263.94B against a $274.44B market cap (0.96x) shows the $4.19B net cash position is immaterial to equity value - it equals just 1.53% of market capitalization - and a 0.73% free-cash-flow yield offers essentially no valuation support if growth or margin progress stalls. Simply Wall St's community split of 11% undervalued against 76% overvalued captures the disagreement, and the decisive fact is that the $247.25 mean target now sits 8.40% BELOW spot. No reliable historical-multiple series or fully matched peer set is supplied, so this is a judgment call rather than a mechanical conclusion - but the judgment is that current profitability does not validate the premium, and three consecutive up sessions widened the gap further.
技术面
Bullish
趋势质量
The October 27 session extended rather than reversed the October 23-26 reversal. CRWD closed at $268.02, up 2.36% (+$6.19) from $261.83, for a third consecutive close above the rising at $256.077 (now 4.66% above it) and an intraday high of $271.03 that traded into the $268.95 September 30 high and the $270.04 October 2 close - the first visit to that shelf since the October 7 breakdown. The stock opened at $260.89 and never traded below $260.34, holding well above the $254.06 October 26 low. Overhead resistance now sits at the $271.03 session high, the $273.535 October 2 intraday high and $274.23 October 5 high, with the $286.99 52-week high 7.1% above spot. The long-term structure was never in question: price is 12.42% above the at $238.412 and 50.67% above the at $177.881, while the sits 34.03% above the , so the golden cross remains firmly intact. The setup is now an intact bull market pressing directly into the September supply shelf after a 12.64% three-session advance rather than a distribution pattern - but the approach is happening on falling volume, which is the one element that keeps this from being unambiguously bullish.
财报
34天
Improving
For the July 31, 2026 quarter, of $0.31 beat the $0.29141 consensus by 6.38%; across the six supplied quarters the average surprise is roughly 5.94%, though the pattern is uneven - 10.62% in April 2025 and 12.05% in July 2025 compressed to 1.98% and 1.56% in the October 2025 and January 2026 quarters before recovering to 3.05% and then 6.38%. Caveats: only six quarters are supplied rather than eight, the April 2025 $0.73 observation is an outlier versus adjacent quarters ($0.2325 in July 2025), and annual consensus dollars remain 1.8% below their 60-day level; the event_calendar now confirms the next report on December 1, 2026 at 34 days out, so the beat pattern faces its next test inside the six-month horizon but just outside the immediate 30-day one.
新闻
Mixed-Bullish
新闻基调
There is no new fundamental news in the bundle - the newest article is still dated September 30 - so the single most important item is the absence of a catalyst for a 12.64% three-session advance that has now pushed CRWD 8.40% above the consensus mean target on declining volume. The Falcon listing in the OpenAI Marketplace remains the only plausible fundamental driver that could organically justify a 166.34x forward multiple, but no bookings, revenue, joint-customer counts, sales-cycle changes or AI-focused deal sizes have been disclosed. The next scheduled opportunity to quantify it is now confirmed as the December 1, 2026 report, 34 days out - which makes that print the dominant binary for anyone holding this stock beyond the next month.
宏观
Neutral
4.99% 10Y / 17.5 VIX
fell 4.73% to 17.52 - still inside the 15-20 Neutral band - and the 10-year edged up to 4.99% from 4.986%, so the discount-rate drag on a 166.34x forward-multiple name is unchanged, but the risk-on bid (Nasdaq +1.18%, Russell 2000 +1.16%, S&P 500 +0.60%) let CRWD push into the September supply zone, meaning falling volatility and momentum flow are currently offsetting rather than reversing the rate headwind.
稳定性
High-Beta Growth
Satellite Upside
CrowdStrike pairs a genuinely durable enterprise-cybersecurity franchise - 25.8% year-over-year revenue growth, a 75.19% gross margin and $1.995B of trailing free cash flow against only $820.18M of debt - with a valuation governed entirely by the multiple rather than by reported earnings: forward 166.34x on next-year of $1.61123, trailing 5,360.4x, price-to-sales 50.86x, 6.76, price-to-book 53.79x, roughly 2,470x and a -2.26% GAAP operating margin. The $4.19B net cash position equals only 1.53% of the $274.44B market cap, so it cushions but cannot anchor the price. The equity is structurally volatile - 56.3% 20-day realized volatility, a $12.57 (4.69% of price), beta 1.197 and a $23.12 single-session range on October 23 - so 5-8% daily moves are normal behavior, not anomalies, and the three-session 12.6% advance is simply that volatility working in the holder's favor for now. It belongs in a smaller Satellite Upside sleeve sized so that a 30%+ sentiment-driven drawdown is survivable, and with a 0.0% dividend yield and a 0.73% free-cash-flow yield it cannot be relied on for income or downside defense.
分析师目标区间
均值目标
$247.25
高低目标
$132 / $325
分析师中值目标
$250.00
共识区间
$132 - $325
— 位分析师
Mean
$132$247$325
市场共识
The October 27 close of $268.02 is now 8.40% ABOVE the $247.25 mean target and 7.21% above the $250.00 median - the widest overshoot of this run, up from 5.57% and 4.73% on October 26 - so the sell side must revise rather than defend. The $325 high target implies 21.3% upside while the $132 low implies roughly 50.7% downside, an unusually wide spread of $193, or about 72.0% of the current price, signalling genuine disagreement about what multiple the business deserves. The rating tally is 10 Strong Buy, 30 Buy, 12 Hold, 0 Sell and 1 Strong Sell across 53 ratings and has barely moved in three months (10/31/11/0/1 at -3m), but the separately reported number-of-analysts field for price targets is null. A bullish rating mix paired with a mean target 8.4% below spot is the classic signature of stale ratings lagging a fast-moving price - it is neither a fresh endorsement nor a warning on its own, but consensus-implied upside can no longer be cited as support at all.
筹码脉冲
内部人信号
Neutral
净偏向
No recent activity
内部人持股
1.3%
机构持股
77.9%
解读
The supplied record establishes neither discretionary buying, discretionary selling, nor 10b5-1 activity, so it carries no reliable directional signal about management's confidence, and the absence of any meaningful Form-4 activity should be treated as information-free rather than as a bullish or bearish tell - which is especially relevant after a three-session 12.6% advance ($237.94 on October 22 to $268.02) that insiders were evidently not trading into.
重要活动
The extract contains a single record: Director Laura J. Schumacher, 39 shares, direct ownership. Transaction type is blank and value_usd is null, and the date field reads only '149', so the entry cannot be classified as a purchase or a sale. At the $268.02 close that position is worth roughly $10,453 - immaterial whatever the direction, and far too small to register against a $274.44B market capitalization.
市场背景
行业
Software - Infrastructure
Neutral
情绪
7
跟踪股票
10
分组
industry
Software - Infrastructure 行业 当前情绪为 Neutral，板块平均评分约 54 分，整体偏稳，且leadership is concentrated in MSFT, PLTR, ORCL。
The relevant sector is Software - Infrastructure, specifically enterprise cybersecurity wrapped around increasingly common enterprise AI workflows. The OpenAI Marketplace listing and the reported Tamnoon and Salt integrations strengthen both distribution and product-use-case breadth, and Morgan Stanley's September 30 Okta note explicitly frames agentic identity as the next growth vector, evidence the narrative has reached the buy side. The October 23-27 advance suggests capital is willing to pay up for the theme again, but none of it is yet quantified: the supplied article itself frames the test as whether management breaks out Marketplace-driven wins or reports shorter sales cycles and larger AI-focused deal sizes, and none of that exists in the bundle. The theme is strengthening narratively while its contribution to estimates remains speculative - three up sessions showed it can carry the stock back through the and into the September supply zone, but not that it can justify 166.34x forward earnings on its own.
Falcon's placement inside the procurement workflow of OpenAI enterprise customers, combined with the buy side's new focus on agentic identity, has put AI-agent security back at the center of cybersecurity positioning, and the December 1, 2026 earnings date is now a confirmed 34-day-away venue for disclosure.
Eligible OpenAI enterprise customers can apply a portion of existing OpenAI commitments toward Falcon procurement, linking security spend to an already-funded AI budget rather than requiring a new line item.
The next earnings report is now confirmed for December 1, 2026 at 34 days out - the next scheduled venue for disclosure on Marketplace-sourced bookings, joint-customer growth or AI-focused deal sizes, making it the natural catalyst for the theme.
The only dated company-specific analyst actions in the bundle are all price-target increases with ratings maintained (Mizuho, Keybanc, Citigroup, Freedom Broker, BTIG), so conviction is being expressed through targets rather than through fresh initiations - the upgrade count over 90 days is zero.
Long-Duration Software De-Rating
评分: -35
Mixed-Bearish
CRWD remains one of the most duration-sensitive large caps with a 166.34x forward , 50.86x price-to-sales and a 6.76 , and the October 27 tape was openly friendly - fell 4.73% to 17.52, the Nasdaq rose 1.18% and the Russell 2000 1.16% - yet the 10-year ticked up to 4.99% and the multiple still expanded because the stock rose 2.36%. That is the key evidence: the multiple is no longer trading on the discount rate but on stock-specific flow, which cuts both ways - it can ignore a flat-to-rising yield on the way up and ignore a falling yield on the way down. De-rating pressure still caps the re-rating potential until either earnings inflect or sentiment toward long-duration software improves materially, and three up sessions made the starting multiple higher, not lower.
The 10-year Treasury at roughly 4.99% remains near the top of its recent range while CRWD's forward multiple rose to 166.34x from 162.50x in one session on no fundamental news, so the gap between the discount rate and the multiple being paid has widened again.
CRWD closed 8.40% above its $247.25 mean consensus target and 7.21% above the $250 median, so sell-side upside must be revised upward before it can be cited as support again.
Morgan Stanley's September 30 Okta note describes investor interest broadening toward Okta and Fortinet, with SentinelOne and SailPoint considered in some cases, framing CRWD's roughly 50x sales multiple as a relative-value hurdle rather than a default allocation.
of 6.76, price-to-book of 53.79x and a 0.73% free-cash-flow yield leave no valuation-based floor if estimate momentum stalls.
关键指标
23 项指标
市值
$274.44B
市盈率 (TTM)
5360.4
远期市盈率
166.3
营收增速
25.8%
净资产收益率
1.5%
Beta 系数
1.20
完整指标集
另外 17 项指标
估值结构
估值倍数与现金流框架。
市销率
50.9
市净率
53.8
企业价值 / EBITDA
2469.9
质量与资产负债表
利润率、杠杆与流动性。
毛利率
75.2%
营业利润率
-2.3%
资产负债率
16.0
流动比率
1.57x
速动比率
1.37x
仓位与价格区间
空头仓位与52周区间位置。
流通盘空头占比
2.6%
空头回补天数
2.26x
52周最高
$286.99
52周最低
$85.68
距52周高点
-6.6%
距52周低点
212.8%
公司分类
板块与行业背景。
板块
Technology
行业
Software - Infrastructure
其他信号
自由现金流
$1995385472.00
详细分析
估值
At $268.02 the trailing of 5,360.4x is not decision-useful given a 0.834% net profit margin, and the decision-useful number is the forward of 166.34x measured on next-year consensus of $1.61123 - up from 162.50x on October 26 and 159.86x on October 23 purely because the price gained another 2.36%, on an otherwise unchanged fundamental base. That means a full year of expected ~28.2% growth ($1.25679 to $1.61123) is already embedded: if the multiple merely holds at 166.34x the stock returns only that growth, and any positive excess return requires further multiple expansion from an already extreme level. A rerating to 140x next-year implies roughly $225.57 (-15.8% from spot), 125x about $201.40 (-24.9%) and 110x about $177.24 (-33.9%), in every case with estimates unchanged. Price-to-sales of 50.86x compares with the roughly 3.7x Software-industry average and 14.9x peer-group average cited in the September 30 Simply Wall St article, though those benchmarks are indicative rather than a fully matched peer study; is 6.76, more than 4x the customary 1.5x growth-stock reference; price-to-book is 53.79x. of about 2,470x is economically uninformative at a 1.98% margin. Enterprise value of $263.94B against a $274.44B market cap (0.96x) shows the $4.19B net cash position is immaterial to equity value - it equals just 1.53% of market capitalization - and a 0.73% free-cash-flow yield offers essentially no valuation support if growth or margin progress stalls. Simply Wall St's community split of 11% undervalued against 76% overvalued captures the disagreement, and the decisive fact is that the $247.25 mean target now sits 8.40% BELOW spot. No reliable historical-multiple series or fully matched peer set is supplied, so this is a judgment call rather than a mechanical conclusion - but the judgment is that current profitability does not validate the premium, and three consecutive up sessions widened the gap further.
资产负债表
Total cash of $5.0138B covers $820.18M of debt about 6.11x, leaving approximately $4.19B of net cash; debt-to-equity is only 15.96% and operating-cash-flow-to-debt is 2.46x. Operating cash flow of $2.0166B is essentially equal to free cash flow of $1.9954B, evidencing near-100% cash conversion and very low capital intensity. Current and quick ratios of 1.57 and 1.37 are adequate for a software platform carrying deferred revenue. The caveat is scale and returns: $4.19B of net cash equals only about 1.53% of the $274.44B market capitalization, so it cushions but cannot offset a 166.34x forward earnings multiple, and reported returns remain weak with of 1.46% and of -0.78%.
增长
Revenue growth of 25.8% year over year remains strong at this scale and is the core support for the premium multiple. The July 2026 quarter's $0.31 of was roughly 33% above the $0.2325 reported a year earlier, and the sequential path excluding the anomalous April 2025 $0.73 print reads 0.2325, 0.24, 0.28, 0.275, 0.31 - a rising trajectory. Near-term consensus is drifting higher (current-quarter $0.31146 versus $0.31040 ninety days ago, next-quarter $0.35708 versus $0.35323) but annual consensus is still not improving in absolute terms: current-year of $1.25679 is 1.8% below its 60-day level of $1.27992 and 2.0% below its 90-day level of $1.2818, while next-year of $1.61123 is 1.2% below its 60-day level of $1.63018 and 1.05% below its 90-day level of $1.62848. Gross margin is high at 75.19%, but GAAP operating margin remains negative at -2.26% and margin is only 1.98%, so operating leverage has yet to appear in reported profitability. The bundle's earnings_growth_yoy field is null and no quarterly revenue or margin time series is supplied, so margin-expansion direction cannot be verified from the data.
生意质量
CrowdStrike's 75.19% gross margin, roughly $2.0B of trailing free cash flow and entrenched position in enterprise endpoint, cloud and identity security underpin real pricing power and platform quality. That quality is offset by a -2.26% GAAP operating margin, a 1.98% margin, a 0.834% net profit margin, 1.46% and -0.78% , which make current reported returns a thin foundation for the prevailing multiple. Liquidity is sound with current and quick ratios of 1.57 and 1.37. Institutional ownership is 77.86% and insider ownership 1.35%; short interest is 2.60% of float with a 2.26-day short ratio, implying neither a crowded short nor a durable squeeze setup, and because no historical short series is supplied it is impossible to tell whether bearish conviction is building. is 1.197 and 20-day realized volatility is 56.3%, so the equity is materially more volatile than the market before valuation risk is even considered. The franchise supports a premium multiple; these profitability metrics do not validate the full premium.
资本配置
CrowdStrike is self-funding with $5.0138B of cash, $820.18M of debt and nearly $2.0B of trailing free cash flow, and enterprise value of $263.94B versus a $274.44B market cap (0.96x) confirms that net cash is immaterial relative to equity value. The company pays no dividend (0.0% yield and 0.0% payout ratio) and therefore offers no shareholder-yield cushion against multiple compression. Shares outstanding are approximately 1.024B with a float of 1.008B, but the bundle provides no share-count time series and no detailed buyback data, so dilution or repurchase intensity cannot be evaluated and returns on specific recent capital deployments cannot be assessed. The overall read is that investment can be fully internally funded, but capital allocation is not currently delivering a material offset to valuation risk.
预期修正
Revision breadth remains strongly positive even though annual consensus dollars sit below where they were 60 and 90 days ago. Over the last 30 days, current-year shows 48 upward versus 1 downward revision and next-year 42 up versus 4 down; near-term quarters are less one-sided at 16 up versus 11 down for the current quarter and 25 up versus 11 down for the following quarter, and the quarterly trend lines are modestly higher over 90 days ($0.31146 versus $0.31040 for the current quarter, $0.35708 versus $0.35323 for the next). Over the past week the only change is one upward revision to next-year and one downward to current-year, i.e. effectively flat. Sell-side price targets kept rising into and after the breakout: Mizuho to $275 from $250 (October 22), Keybanc to $265 from $245 (October 16), Citigroup to $295 from $260 (October 15), Freedom Broker to $320 from $260 and BTIG to $312 from $245 (October 14). Yet annual dollars remain 1.8%/1.2% below their 60-day levels, the bundle records zero formal upgrades, zero downgrades and zero initiations over the last 90 days, and the consensus mean has only drifted to $247.25 - still 8.40% below spot. The hikes reflect multiple tolerance and conviction rather than an upward reset in earnings power.